In epidermal growth factor receptor (EGFR) vIII GBM cells, the p38-MAPKAPK2-human antigen R (HuR) pathway could enhance IL-6 secretion induced by IL-1β (17). Here, MAPKAPK2 is linked to glioblastoma.